124 results on '"Lestavel S"'
Search Results
2. Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans
3. A novel splice site mutation of the LDL receptor gene in a Tunisian hypercholesterolemic family
4. CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemia
5. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families
6. CO-10: Le récepteur nucléaire FXR inhibe la sécrétion de GLP-1 en réponse aux acides gras à chaîne courte par les cellules entéroendocrines de type L
7. CA-176: Effets du RYGB sur les profils d'acides biliaires systémiques : étude comparative chez le rat, le minipig et l'Homme
8. O21 Le récepteur nucléaire FXR diminue la capacité des cellules L entéroendocrines à répondre au glucose
9. Liver X receptor activation decreases chylomicron assembly and improves post-prandial triglyceridemia via intestinal sr-bi downregulation
10. PO32 L’activation du récepteur nucléaire FXR module la capacité des cellules L entéroendocrines à sécréter GLP-1
11. Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
12. Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages
13. Liver X Receptor Activation Controls Intracellular Cholesterol Trafficking and Esterification in Human Macrophages
14. W15-O-003 Atheroprotective effect of the rexinoid targretin in a murine model of atherosclerosis
15. W15-P-005 Regulation of genes encoding intestinal cholesterol transporters by nuclear receptors in human CACO-2/TC7 enterocytes
16. Peroxisome Proliferator-Activated Receptor α Reduces Cholesterol Esterification in Macrophages
17. Cholesterol homeostasis is controlled by peroxisome proliferator-activated receptor alpha in human macrophages
18. PPAR (peroxisome proliferator-activated receptors) et paroi vasculaire : implications dans l'athérosclérose.
19. PPARs regulate genes involved in cholesterol homeostasis in human monocyte/macrophages
20. Localisation of SR-BI in caveolae is not required for cholesteryl esters selective uptake in NCI H295R adrenal cell line
21. Apolipoprotein AII is a better ligand than apolipoprotein AI for the human HDL receptor SR-BI but alters specific cholesteryl ester uptake in human adrenal cell line
22. A High Concentration of Melatonin Inhibits In Vitro LDL Peroxidation But Not Oxidized LDL Toxicity Toward Cultured Endothelial Cells
23. 4.P.348 Caveolae and glycosyl phosphatidylinositol-anchored proteins: A specific binding membrane domain for high density lipoproteins
24. 1.P.258 Mutation screening in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay
25. Immunological and functional properties of in vitro oxidized low density lipoprotein.
26. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes
27. The Novel PPARalpha-Selective Agonist K-877 Improves Dyslipidemia, Enhances Reverse Cholesterol Transport and Decreases Inflammation and Atherosclerosis
28. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L-cells
29. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
30. PPAR alpha and PPAR gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABC-1 pathway
31. PPAR alpha controls cholesterol homeostasis in human monocyte-derived macrophages
32. Peroxisome proliferator-activated receptors in human atherosclerosis
33. Corrigendum to "Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis" [Mol Metab 69 (2023) 1-13].
34. Genetic Evidence of Causal Relation Between Intestinal Glucose Absorption and Early Postprandial Glucose Response: A Mendelian Randomization Study.
35. Discovery, Structure-Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5.
36. Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis.
37. Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes.
38. An Exploratory Study of the Role of Dietary Proteins in the Regulation of Intestinal Glucose Absorption.
39. Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System.
40. Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease.
41. Characterization of one anastomosis gastric bypass and impact of biliary and common limbs on bile acid and postprandial glucose metabolism in a minipig model.
42. Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure-Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor.
43. Inflammation-induced cholestasis in cancer cachexia.
44. The Effect of Lactobacillus fermentum ME-3 Treatment on Glycation and Diabetes Complications.
45. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.
46. Food-Derived Hemorphins Cross Intestinal and Blood-Brain Barriers In Vitro .
47. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction.
48. Ffar2 expression regulates leukaemic cell growth in vivo.
49. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.
50. Intestinal bile acid receptors are key regulators of glucose homeostasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.